Systemic Hormonal Contraceptive Use and Rhinitis Among Adult Women: An All of Us Database Analysis

IF 1.6 4区医学 Q2 OTORHINOLARYNGOLOGY

Laryngoscope Investigative Otolaryngology Pub Date : 2025-03-21 DOI:10.1002/lio2.70123

Richard G. Chiu, Kamal Eldeirawi, Anthony I. Dick, Sharmilee M. Nyenhuis, Thasarat Sutabutr Vajaranant, Rachel Caskey, Victoria S. Lee

{"title":"Systemic Hormonal Contraceptive Use and Rhinitis Among Adult Women: An All of Us Database Analysis","authors":"Richard G. Chiu, Kamal Eldeirawi, Anthony I. Dick, Sharmilee M. Nyenhuis, Thasarat Sutabutr Vajaranant, Rachel Caskey, Victoria S. Lee","doi":"10.1002/lio2.70123","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>The role of sex hormones in the pathogenesis of allergic and inflammatory conditions such as rhinitis has been receiving increased attention, with evidence supporting an inflammation-modulating role of estrogen and progesterone in the nasal mucosa. However, the specific influence of hormonal contraceptives in rhinitis has been sparsely studied. As such, we sought to investigate the association of systemic hormonal contraceptives with both allergic (AR) and nonallergic rhinitis (NAR) using a national data set of adults in the United States.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This study was conducted using data from 46,205 female participants aged 20–40 in the <i>All of Us</i> Research Program. Rhinitis diagnoses, systemic hormonal contraceptive use, and covariate data were extracted for all participants. These variables were included in multivariable logistic regression models assessing the association of any systemic hormonal contraceptive use with rhinitis, both AR and NAR. Separate models were conducted to examine the association of progestin-only contraceptives (POCs) and estrogen-containing contraceptives (ECCs) on the odds of rhinitis. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Systemic hormonal contraceptives were associated with AR (OR: 1.32; 95% CI: 1.20–1.44) but not NAR (OR: 1.20; 95% CI: 0.90–1.56) after controlling for covariates. When analyzing POCs and ECCs separately, both were associated with AR compared to those not taking any systemic hormonal contraceptives (OR: 1.29; 95% CI: 1.12–1.48 for POC, OR: 1.35; 95% CI: 1.21–1.51 for ECC) but were not significantly associated with NAR (OR: 1.04; 95% CI: 0.66–1.57 for POC, OR: 1.33; 95% CI: 0.95–1.81 for ECC).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Systemic hormonal contraceptive use was independently associated with AR, with no significant difference between POCs and ECCs, while not being associated with NAR. Our findings may support a hormonal role in the pathogenesis of AR, but further research is needed to establish causation and understand the underlying mechanisms linking systemic hormonal contraceptive use to AR.</p>\n </section>\n \n <section>\n \n <h3> Level of Evidence</h3>\n \n <p>3.</p>\n </section>\n </div>","PeriodicalId":48529,"journal":{"name":"Laryngoscope Investigative Otolaryngology","volume":"10 2","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lio2.70123","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope Investigative Otolaryngology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lio2.70123","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

The role of sex hormones in the pathogenesis of allergic and inflammatory conditions such as rhinitis has been receiving increased attention, with evidence supporting an inflammation-modulating role of estrogen and progesterone in the nasal mucosa. However, the specific influence of hormonal contraceptives in rhinitis has been sparsely studied. As such, we sought to investigate the association of systemic hormonal contraceptives with both allergic (AR) and nonallergic rhinitis (NAR) using a national data set of adults in the United States.

Methods

This study was conducted using data from 46,205 female participants aged 20–40 in the All of Us Research Program. Rhinitis diagnoses, systemic hormonal contraceptive use, and covariate data were extracted for all participants. These variables were included in multivariable logistic regression models assessing the association of any systemic hormonal contraceptive use with rhinitis, both AR and NAR. Separate models were conducted to examine the association of progestin-only contraceptives (POCs) and estrogen-containing contraceptives (ECCs) on the odds of rhinitis. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated.

Results

Systemic hormonal contraceptives were associated with AR (OR: 1.32; 95% CI: 1.20–1.44) but not NAR (OR: 1.20; 95% CI: 0.90–1.56) after controlling for covariates. When analyzing POCs and ECCs separately, both were associated with AR compared to those not taking any systemic hormonal contraceptives (OR: 1.29; 95% CI: 1.12–1.48 for POC, OR: 1.35; 95% CI: 1.21–1.51 for ECC) but were not significantly associated with NAR (OR: 1.04; 95% CI: 0.66–1.57 for POC, OR: 1.33; 95% CI: 0.95–1.81 for ECC).

Conclusion

Systemic hormonal contraceptive use was independently associated with AR, with no significant difference between POCs and ECCs, while not being associated with NAR. Our findings may support a hormonal role in the pathogenesis of AR, but further research is needed to establish causation and understand the underlying mechanisms linking systemic hormonal contraceptive use to AR.